Streetbeat News

Revenues

NVCR

NovoCure (NASDAQ:NVCR) has received mixed analyst ratings over the past three months, with a recent average price target of $28.0. Analysts have adjusted their ratings and price targets, reflecting their views on the company's market position and financial performance. NovoCure has shown strong revenue growth but faces challenges with profitability and asset returns.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 5:00 pm

BX

Blackstone's BREIT struggles to meet performance fee thresholds, impacting its earnings outlook. BREIT's modest gains in September were insufficient to trigger third-quarter performance fees, leading JPMorgan to lower its revenue projections for Blackstone's real estate segment. The fund faces significant challenges in achieving the necessary performance for future quarters.

Portfolio Pulse from Henry Khederian

October 16, 2024 | 4:51 pm

CTAS

Cintas (NASDAQ:CTAS) has significantly outperformed the market over the past 15 years, with an annualized return of 25.31%. A $1000 investment in Cintas 15 years ago would be worth $29,553.62 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 4:31 pm

MMC

Marsh & McLennan (NYSE:MMC) has outperformed the market over the past 15 years with an average annual return of 15.76%, surpassing the market by 3.99% annually. A $1000 investment in MMC 15 years ago would now be worth $9,254.28.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 4:31 pm

SCHW

Charles Schwab Corporation reported better-than-expected Q3 results, with a 5% revenue increase and a 9% rise in daily average trades. Analysts have mixed views, with JPMorgan and JMP Securities maintaining positive ratings and raising price targets, while Goldman Sachs remains cautious. Piper Sandler is cautiously optimistic about future trends.

Portfolio Pulse from Erica Kollmann

October 16, 2024 | 4:31 pm

ASPN

Aspen Aerogels shares rise following a conditional commitment for a DOE loan of up to $670.6 million. The company anticipates its second plant to generate $1.2 to $1.6 billion in revenue.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 4:21 pm

BB

BlackBerry Ltd has projected its fiscal year 2025 revenue to be between $350 million and $365 million, with expectations of break-even results. The company is also exploring strategic options for its Cylance business.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2024 | 4:09 pm

GNRC

Analysts have varied opinions on Generac Holdings (NYSE:GNRC), with a mix of bullish and somewhat bullish ratings. Recent analyst actions show several raised price targets, indicating positive sentiment. The average 12-month price target has increased by 12.96%. Despite revenue challenges, Generac's profitability metrics like net margin, ROE, and ROA exceed industry averages, and its debt management is strong.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 4:00 pm

WPM

Wheaton Precious Metals (NYSE:WPM) has delivered an impressive annualized return of 18.82% over the past 5 years, outperforming the market by 4.63%. A $100 investment in WPM 5 years ago would now be worth $238.15, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 4:00 pm

CB

Chubb (NYSE:CB) has significantly outperformed the market over the past 20 years, with an annualized return of 11.55%. A $100 investment in Chubb 20 years ago would be worth $889.37 today, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 16, 2024 | 4:00 pm